BioCentury | Feb 18, 2010
Targets & Mechanisms

Turning up the heat on HD

...Therapeutics Inc. Heat shock transcription factor 1 (HSF1) agonist Small molecule activators of HSF1 Preclinical Medesis Pharma...
BioCentury | Nov 16, 2009
Clinical News

NP03 regulatory update

...for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation to Medesis'...
...formulation technology is in preclinical testing. Medesis hopes to start Phase I/II testing in mid-2010. Medesis Pharma...
Items per page:
1 - 2 of 2
BioCentury | Feb 18, 2010
Targets & Mechanisms

Turning up the heat on HD

...Therapeutics Inc. Heat shock transcription factor 1 (HSF1) agonist Small molecule activators of HSF1 Preclinical Medesis Pharma...
BioCentury | Nov 16, 2009
Clinical News

NP03 regulatory update

...for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation to Medesis'...
...formulation technology is in preclinical testing. Medesis hopes to start Phase I/II testing in mid-2010. Medesis Pharma...
Items per page:
1 - 2 of 2